X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.prnewswire.com/news-releases/sun-pharma-announces-drizalma-sprinkle-duloxetine-delayed-release-capsules-is-now-covered-by-most-medicare-part-d-plans-301242824.html#:~:text=%22We%20are%20pleased%20to%20have,Ophthalmics%2C%20Oncology%20and%20LTC%20at
https://www.globenewswire.com/news-release/2020/07/08/2059215/0/en/OWP-Pharmaceuticals-Announces-Patent-Application-for-the-First-Ever-Powder-for-Oral-Liquid-Formulation-of-Duloxetine-Hydrochloride-for-the-Treatment-of-Major-Depressive-and-General.html
https://www.fiercebiotech.com/biotech/jpm-conversation-steve-paul-ceo-karuna-therapeutics
https://www.business-standard.com/article/pti-stories/sun-pharma-launches-drizalma-sprinkle-in-us-119101600600_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207219
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210599
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211310
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203088
https://www.prnewswire.com/news-releases/breckenridge-announces-approval-for-40mg-duloxetine-delayed-release-capsules-additional-strength-300652166.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-cadila-recall-drugs-in-us-market/articleshow/61970686.cms
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-6-2017-1512536772.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-8-2017-1510120910.pdf
http://www.financialexpress.com/market/ajanta-pharma-stocks-tumbles-as-us-fda-issues-import-alert-on-its-kamagra-drug/519956/
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208706
http://www.drugregulations.org/2016/08/ten-generic-drugs-to-be-withdrawn-in-uk.html
https://www.pharmacompass.com/pdf/news/hetero-labs-generic-duloxetine-hydrochloride-approved-in-usa-1470466910.pdf
http://www.fiercepharma.com/manufacturing/apotex-recalling-nearly-1-5-million-bottles-antidepressant
http://www.bloomberg.com/news/articles/2016-03-10/teva-wins-conditional-eu-approval-for-allergan-generics-deal
http://www.bloomberg.com/news/articles/2016-02-17/teva-said-to-seek-fast-eu-approval-for-allergan-unit-bid-ikqudz16
http://www.business-standard.com/article/opinion/rebound-in-us-sales-a-big-positive-for-lupin-116020500981_1.html
http://www.fiercepharma.com/story/riding-q4-diabetes-growth-lilly-aims-even-more-jardiance/2016-01-28
http://www.fiercepharma.com/story/lilly-falls-short-analyst-forecasts-2016-guidance-weaker-end/2016-01-05
http://www.fiercepharma.com/story/how-much-more-does-us-pay-drugs-10-times-more-report-says/2015-09-28
http://www.fiercepharma.com/story/top-selling-drugs-might-be-first-line-medicare-price-negotiations/2015-09-23
http://www.fiercepharma.com/story/lilly-chalks-win-cymbalta-first-us-trial-over-withdrawal-symptom-claims/2015-08-10
http://www.bloomberg.com/news/articles/2015-08-07/eli-lilly-wins-first-trial-over-antidepressant-s-brain-zaps-
http://www.reuters.com/article/2015/08/03/us-eli-lilly-cymbalta-trial-idUSKCN0Q825220150803
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/06/news_detail_002350.jsp&mid=WC0b01ac058004d5c1
http://www.bloomberg.com/news/articles/2015-06-24/lilly-facing-first-trials-over-cymbalta-withdrawal-warnings
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/003981/WC500188517.pdf
http://www.pmlive.com/pharma_news/humira_remains_top_pharma_product,_but_sovaldi_closes_in_750137
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
http://www.pharmatimes.com/Article/15-04-26/Eleven_medicines_leap_closer_to_approval_in_Europe.aspx
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/04/news_detail_002310.jsp&mid=WC0b01ac058004d5c1
http://www.fiercepharma.com/story/eli-lilly-can-thank-novartis-and-low-expectations-its-q1-earnings-beat/2015-04-23
http://www.pmlive.com/pharma_news/german_court_overturns_patent_on_lilly_blockbuster_alimta_672825
http://www.fool.com/investing/general/2015/04/05/10-largest-companies-by-market-cap-in-pharmaceutic.aspx
http://www.fiercepharma.com/story/lilly-execs-take-3m-hit-2014-bonuses-pay-freeze-thaws-2015/2015-03-30
http://www.ibj.com/articles/52383-pay-dips-but-pension-values-soar-for-lillys-top-execs
http://www.prnewswire.com/news-releases/moderate-to-severe-pain-novel-abuse-deterrent-formulation-technologies-and-emergence-of-novel-mechanism-in-the-management-of-pain-300030890.html
http://www.fiercepharma.com/story/moodys-big-pharmas-face-growing-patent-loss-threats-some-pipelines-are-impr/2015-02-03
http://www.alternet.org/personal-health/8-invented-diseases-big-pharma-banking
http://www.pmlive.com/pharma_news/lilly_eyes_pivotal_trials_for_pain_drug_tanezumab_in_2015_642401
http://www.fiercepharma.com/story/lillys-sales-and-earnings-continue-their-free-fall-ceo-lechleiter-sees-good/2015-01-30
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004000/WC500180946.pdf
http://www.uquifa.com/en/news/178-uquifa-and-kern-pharma-partnership-the-launch-duloxetine
Market Place
Share 
